These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 38252704)
61. A Nomogram Including Sarcopenia for Predicting Progression-Free Survival in Patients with Localized Papillary Renal Cell Carcinoma: A Retrospective Cohort Study. Su W; Wu Y; Liao S; Zhang Z; Zhang Y; Ou W; Yu J; Xiang F; Luo C; Zheng F Ann Surg Oncol; 2024 Sep; 31(9):5815-5826. PubMed ID: 38954088 [TBL] [Abstract][Full Text] [Related]
62. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma. Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012 [TBL] [Abstract][Full Text] [Related]
63. Value of Yang B; Ji H; Zhong J; Ma L; Zhong J; Dong H; Zhou C; Duan S; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G Front Oncol; 2020; 10():567160. PubMed ID: 33262942 [TBL] [Abstract][Full Text] [Related]
64. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy. Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809 [TBL] [Abstract][Full Text] [Related]
65. Accurate preoperative staging with [ Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157 [TBL] [Abstract][Full Text] [Related]
66. An 18F-FDG-PET/CT-based radiomics signature for estimating malignance probability of solitary pulmonary nodule. Zheng J; Hao Y; Guo Y; Du M; Wang P; Xin J Clin Respir J; 2024 May; 18(5):e13751. PubMed ID: 38725315 [TBL] [Abstract][Full Text] [Related]
67. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer. Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507 [TBL] [Abstract][Full Text] [Related]
68. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index. Lu X; Tian Y; Huang J; Li F; Shao T; Huang G; Lv X Oral Dis; 2023 Apr; 29(3):923-932. PubMed ID: 34773352 [TBL] [Abstract][Full Text] [Related]
69. A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma. Sun MX; Zhao MJ; Zhao LH; Jiang HR; Duan YX; Li G Radiat Oncol; 2023 Apr; 18(1):67. PubMed ID: 37041545 [TBL] [Abstract][Full Text] [Related]
70. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs. Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L Front Oncol; 2022; 12():894323. PubMed ID: 35800046 [TBL] [Abstract][Full Text] [Related]
71. Prognostic Value of a Combined Nomogram Model Integrating 3-Dimensional Deep Learning and Radiomics for Head and Neck Cancer. Li S; Xie J; Liu J; Wu Y; Wang Z; Cao Z; Wen D; Zhang X; Wang B; Yang Y; Lu L; Dong X J Comput Assist Tomogr; 2024 May-Jun 01; 48(3):498-507. PubMed ID: 38438336 [TBL] [Abstract][Full Text] [Related]
72. Differentiation of early relapse and late relapse in intermediate- and high-risk neuroblastoma with an Feng L; Yao X; Lu X; Wang C; Wang W; Yang J Abdom Radiol (NY); 2024 Mar; 49(3):888-899. PubMed ID: 38315193 [TBL] [Abstract][Full Text] [Related]
73. Development and validation of a prognostic model incorporating [ Cheng NM; Hsieh CE; Fang YD; Liao CT; Ng SH; Wang HM; Chou WC; Lin CY; Yen TC EJNMMI Res; 2020 Jul; 10(1):74. PubMed ID: 32632638 [TBL] [Abstract][Full Text] [Related]
74. Role of Yuan H; Tan X; Sun X; He L; Li D; Jiang L Jpn J Radiol; 2023 May; 41(5):521-530. PubMed ID: 36480105 [TBL] [Abstract][Full Text] [Related]
75. Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma. Lv W; Yuan Q; Wang Q; Ma J; Feng Q; Chen W; Rahmim A; Lu L Mol Imaging Biol; 2019 Oct; 21(5):954-964. PubMed ID: 30671740 [TBL] [Abstract][Full Text] [Related]
76. Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning. Zhou B; Liu J; Yang Y; Ye X; Liu Y; Mao M; Sun X; Cui X; Zhou Q BMC Cancer; 2024 Jul; 24(1):810. PubMed ID: 38972977 [TBL] [Abstract][Full Text] [Related]
77. A novel analytical approach for outcome prediction in newly diagnosed NSCLC based on [ Zhang L; Xu C; Zhang X; Wang J; Jiang H; Chen J; Zhang H Eur Radiol; 2023 Mar; 33(3):1757-1768. PubMed ID: 36222865 [TBL] [Abstract][Full Text] [Related]
78. Evaluating Prognosis of Gastrointestinal Metastatic Neuroendocrine Tumors: Constructing a Novel Prognostic Nomogram Based on NETPET Score and Metabolic Parameters from PET/CT Imaging. Liu Y; Cui R; Wang Z; Lin Q; Tang W; Zhang B; Li G; Wang Z Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543159 [TBL] [Abstract][Full Text] [Related]
79. Body Composition and Radiomics From 18 F-FDG PET/CT Together Help Predict Prognosis for Patients With Stage IV Non-Small Cell Lung Cancer. Zhang Y; Tan W; Zheng Z; Wang J; Xing L; Sun X J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):906-912. PubMed ID: 37948365 [TBL] [Abstract][Full Text] [Related]
80. Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on Huang Y; Jiang X; Xu H; Zhang D; Liu LN; Xia YX; Xu DK; Wu HJ; Cheng G; Shi YH Clin Radiol; 2023 Jan; 78(1):8-17. PubMed ID: 36192203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]